Active variants of human parathyroid hormone (1-34) with multiple amino acid substitutions

Molecular and Cellular Endocrinology

Volumn 160, Issue 1-2, 2000, Pages 135-147

  Reidhaar Olson, John F ^a   Davis, Robyn M ^a   De Souza Hart, Janet A ^a   Selick, Harold E ^a  

^a AFFYMAX RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; LEUCINE; METHIONINE; NORLEUCINE; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE[1-34]; PEPTIDE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN VARIANT; RAT; RECEPTOR BINDING; RECOMBINANT DNA TECHNOLOGY; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; CELL LINE; DNA, RECOMBINANT; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PLASMIDS; RATS; RECEPTORS, PARATHYROID HORMONE; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; VARIATION (GENETICS);

EID: 0034712261     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00211-7     Document Type: Article

References (42)

1. Abou-Samra A.B., Jüppner H., Westerberg D., Potts J.T. Jr., Segre G.V. Parathyroid hormone causes translocation of protein kinase-C from cytosol to membranes in rat osteosarcoma cells. Endocrinology. 124:1989;1107-1113.
2. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current Protocols in Molecular Biology: Vol. l. 1989;Wiley, New York.
3. Barden J.A., Cuthbertson R.M. Stabilized NMR structure of human parathyroid hormone (1-34). Eur. J. Biochem. 215:1993;315-321.
4. Barden J.A., Kemp B.E. NMR solution structure of human parathyroid hormone(1-34). Biochemistry. 32:1993;7126-7132.
5. Chorev M., Goldman M.E., McKee R., Roubini E., Levy J.J., Gay C.T., Reagan J.E., Fisher J.E., Caporale L.H., Golub E.E., Caulfield M.P., Nutt R.F., Rosenblatt M. Modifications of position 12 in parathyroid hormone and parathyroid hormone related protein: toward the design of highly potent antagonists. Biochemistry. 29:1990;1580-1586.
6. Cohen F.E., Strewler G.J., Bradley M.S., Carlquist M., Nilsson M., Ericsson M., Ciardelli T.L., Nissenson R.A. Analogues of parathyroid hormone modified at positions 3 and 6: effects on receptor binding and activation of adenylyl cyclase in kidney and bone. J. Biol. Chem. 266:1991;1997-2004.
7. Dempster D.W., Cosman F., Parisien M., Shen V., Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr. Rev. 14:1993;690-709.
8. Deng W.P., Nickoloff J.A. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:1992;81-88.
9. Gardella T.J., Axelrod D., Rubin D., Keutmann H.T., Potts J.T. Jr., Kronenberg H.M., Nussbaum S.R. Mutational analysis of the receptor-activating region of human parathyroid hormone. J. Biol. Chem. 266:1991;13 141-13 146.
10. Gardella T.J., Luck M.D., Wilson A.K., Keutmann H.T., Nussbaum S.R., Potts J.T. Jr., Kronenberg H.M. Parathyroid hormone (PTH)-PTH-related peptide hybrid peptides reveal functional interactions between the 1-14 and 15-34 domains of the ligand. J. Biol. Chem. 270:1995;6584-6588.
11. Gardella T.J., Wilson A.K., Keutmann H.T., Oberstein R., Potts J.T. Jr., Kronenberg H.M., Nussbaum S.R. Analysis of parathyroid hormone's principal receptor-binding region by site-directed mutagenesis and analog design. Endocrinology. 132:1993;2024-2030.
12. Grant S.G.N., Jessee J., Bloom F.R., Hanahan D. Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proc. Natl. Acad. Sci. USA. 87:1990;4645-4649.
13. Gronwald W., Schomburg D., Harder M.P.F., Mayer H., Paulsen J., Wingender E., Wray V. Structure of recombinant human parathyroid hormone in solution using multidimensional NMR spectroscopy. Biol. Chem. Hoppe-Seyler. 377:1996;175-186.
14. BAD promoter. J. Bacteriol. 177:1995;4121-4130.
15. Heinrich G., Kronenberg H.M., Potts J.T., Habener J.F. Gene encoding parathyroid hormone: nucleotide sequence of the rat gene and deduced amino acid sequence of rat preproparathyroid hormone. J. Biol. Chem. 259:1984;3320-3329.
16. Jouishomme H., Whitfield J.F., Gagnon L., MacLean S., Isaacs R., Chakravarthy B., Durkin J., Neugebauer W., Willick G., Rixon R.H. Further definition of the protein kinase C activation domain of the parathyroid hormone. J. Bone Miner. Res. 6:1994;943-949.
17. Komm B.S., Bodine P.V.N. The ongoing saga of osteoporosis treatment. J. Cell. Biochem. Suppl. 30/31:1998;277-283.
18. Kronenberg H.M., McDevitt B.E., Majzoub J.A., Nathans J., Sharp P.A., Potts J.T. Jr., Rich A. Cloning and nucleotide sequence of DNA coding for bovine preproparathyroid hormone. Proc. Natl. Acad. Sci. USA. 76:1979;4981-4985.
19. Marx U.C., Austermann S., Bayer P., Adermann K., Ejchart A., Sticht H., Walters S., Schmid F.-X., Jaenicke R., Forssmann W.-G., Rosch P. Structure of human parathyroid hormone 1-37 in solution. J. Biol. Chem. 270:1995;15 194-15 202.
20. Miozzari G.F., Yanofsky C. Translation of the leader region of the Escherichia coli tryptophan operon. J. Bacteriol. 133:1978;1457-1466.
21. Mundy G.R. Osteoporosis into the year 2010. Brit. J. Obst. Gyn. 103 Suppl. 13:1996;32-38.
22. Nabuchi Y., Fujiwara E., Ueno K., Kuboniwa H., Asoh Y., Ushio H. Oxidation of recombinant human parathyroid hormone: Effect of oxidized position on the biological activity. Pharm. Res. 12:1995;2049-2052.
23. Nussbaum S.R., Rosenblatt M., Potts J.T. Jr. Parathyroid hormone-renal receptor interactions: demonstration of two receptor-binding domains. J. Biol. Chem. 255:1980;10 183-10 187.
24. Oldenburg K.R., Epand R.F., D'Orfani A., Vo K., Selick H., Epand R.M. Conformational studies on analogs of recombinant parathyroid hormone and their interactions with phospholipids. J. Biol. Chem. 271:1996;17 582-17 591.
25. O'Neil K.T., DeGrado W.F. A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. Science. 250:1990;646-651.
26. Partridge N.C., Block S.R., Pearman A.T. Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression. J. Cell. Biochem. 55:1994;321-327.
27. Potts J.T. Jr., Tregear G.W., Keutmann H.T., Niall H.D., Sauer R., Deftos L.J., Dawson B.F., Hogan M.L., Aurbach G.D. Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc. Natl. Acad. Sci. USA. 68:1971;63-67.
28. Reidhaar-Olson J.F., Bowie J.U., Breyer R.M., Hu J.C., Knight K.L., Lim W.A., Mossing M.C., Parsell D.A., Shoemaker K.R., Sauer R.T. Random mutagenesis of protein sequences using oligonucleotide cassettes. Methods Enzymol. 208:1991;564-586.
29. Rosenblatt M., Kronenberg H.M., Potts J.T. Jr. Parathyroid hormone: physiology, chemistry, biosynthesis, secretion, metabolism, and mode of action. DeGroot L.J. Endocrinology. 1989;848-891 Saunders, Philadelphia.
30. Rosenblatt M., Segre G.V., Tyler G.A., Shepard G.L., Nussbaum S.R., Potts J.T. Jr. Identification of a receptor-binding region in parathyroid hormone. Endocrinology. 107:1980;545-550.
31. Rosol T.J., Steinmeyer C.L., McCauley L.K., Grone A., DeWille J.W., Capen C.C. Sequences of the cDNAs encoding canine parathyroid hormone-related protein and parathyroid hormone. Gene. 160:1995;241-243.
32. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
33. Schmelzer H.J., Gross G., Widera G., Mayer H. Nucleotide sequence of a full-length cDNA clone encoding preproparathyroid hormone from pig and rat. Nucleic Acids Res. 15:1987;6740.
34. Seyle H. On the stimulation of new bone-formation with parathyroid extract and irradiated ergosterol. Endocrinology. 16:1932;547-558.
35. Strickland L.A., Bozzato R.P., Kronis K.A. Structure of human parathyroid hormone(1-34) in the presence of solvents and micelles. Biochemistry. 32:1993;6050-6057.
36. Tanizawa T., Yamamoto N., Takano Y., Mashiba T., Zhang L., Nishida S., Endo N., Takahashi H.E., Fujimoto R., Hori M. Effects of human PTH (1-34) and bisphosphonate on the osteopenic rat model. Toxicol. Lett. 102-103:1998;399-403.
37. Wells J.A. Additivity of mutational effects in proteins. Biochemistry. 29:1990;8509-8517.
38. Wells J.A., Cunningham B.C., Graycar T.P., Estell D.A. Importance of hydrogen-bond formation in stabilizing the transition state of subtilisin. Philos. Trans. R. Soc. Lond. A. 317:1986;415-423.
39. Wells J.A., Vasser M., Powers D.B. Cassette mutagenesis: an efficient method for generation of multiple mutations at defined sites. Gene. 34:1985;315-323.
40. 1H NMR spectroscopy and its biological implications. Biochemisrty. 33:1994;1684-1693.
41. Zell R., Fritz H.-J. DNA mismatch-repair in Escherichia coli counteracting the hydrolytic deamination of 5-methyl-cytosine residues. EMBO J. 6:1987;1809-1815.
42. Zhang L., Takahashi H.E., Inoue J., Tanizawa T., Endo N., Yamamoto N., Hori M. Effects of intermittent administration of low dose human PTH (1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone. 21:1997;501-506.